NITECORE Sets a New Standard for Ultralight Power: the New 143g, IPX7-Rated NB10000 Gen4
GUANGZHOU, China, Feb. 5, 2026 /PRNewswire/ -- The NITECORE NB10000 Gen4 Ultra Lightweight Competition-Grade Power Bank, available since January 29, 2026, has quickly become a trusted power solution for users worldwide. It addresses the growing need...
DLG Launches LuxuryIQ MCP: The Luxury Industry's First AI Data Integration Layer
GENEVA, Feb. 5, 2026 /PRNewswire/ -- DLG (Digital Luxury Group) today announces LuxuryIQ MCP, the first Model Context Protocol integration designed specifically for the luxury industry. The integration gives luxury executives natural-language access...
Top 10 News Stories on 2025 Lancang-Mekong Cooperation Released in Luang Prabang
LUANG PRABANG, Laos, Feb. 5, 2026 /PRNewswire/ -- A report by China Report ASEAN: The list of Top 10 News Stories on 2025 Lancang-Mekong Cooperation was officially released on the evening of February 4 (Beijing time) in Luang Prabang, Laos,...
AutoFlight Unveils World's First 5-Ton Class eVTOL Aircraft
Matrix successfully demonstrates full transition flight capability Pioneering aircraft available in 10-seat passenger and 1,500kg cargo configurations SUZHOU, China, Feb. 5, 2026 /PRNewswire/ -- AutoFlight has unveiled Matrix, the world's first...
Ocean Tomo Bolsters Radio Frequency, Wireless, and Spectrum Expertise with Addition of Director Dan Sleeter
Sleeter's background spanning defense, telecommunications, aerospace, and secure mission systems strengthens the firm's technical leadership in wireless technology reverse engineering and patent claim analysis. NEW YORK, Feb. 5, 2026 /PRNewswire/ --...
Massimo Group Showcases MVR HVAC Pro Series at the GCSAA Conference, Accelerating Dealer, Fleet and International Expansion
GARLAND, Texas, Feb. 5, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and advanced electric mobility solutions, today announced its participation in the 2026 Golf Course Superintendents...
Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory cytokines IL-1β and IL-18, and ISM5059 targets systemic inflammatory conditions by targeting NLRP3 and blocking the inflammatory cascade at its source. Unlike...
Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors
Leah Goodman brings a wealth of policy and regulatory experience and is a recognized leader in Australia for advancing scientific discoveries to patient impacts. CALGARY, AB and BRISBANE, Australia, Feb. 5, 2026 /PRNewswire/ -- Providence...